MOLECULAR MARKERS AND CANCER THERAPEUTICS

On behalf of Molecular Markers 2018, we take immense pleasure in welcoming Oncologists, Molecular Biologists, Cell Biologists, Cancer Researchers, Business professionals and Delegates present all over the world to participate in our conference which is to be held in Dubai, UAE during October 08-09, 2018. This gathering is a rostrum that offers great opportunity to update to the latest research in Cancer Molecular Markers and Therapeutics. Our conference is organized around the theme: “Clinical Advancements in Discovery of Molecular Markers in Cancer Treatment”.


Our Conference highlights include: Molecular Markers, Immuno-Oncology Biomarkers, Neurological Biomarkers, Cardio-Vascular Biomarkers, Clinical and Translational Biomarkers, Biomarkers in Personalized Medicine, Biomarkers in Cell Biology, Biomarkers in Medicine, Mapping of Genetic Biomarkers, Biochemical Markers, Digital Biomarkers, Cancer Causes and Diagnosis, Cancer Biomarkers and Therapeutics, Imaging Biomarkers, Next-Generation Sequencing for Disease Biomarkers

Cancer is the uncontrolled growth of abnormal cells in the body. Cancer is not limited by gender, age, or ethnicity and has no physical barriers within the body. Through the “International Conference on Molecular Markers and Cancer Therapeutics”, we provide a vast platform for people in various fields to discuss in deep about important therapeutic advances in oncology.

For more information, go through: https://molecularmarkers.cancersummit.org/

Contact: Rachel Alex
E-mail: molecularmarkers@oncologyconferences.org

Comments

Post a Comment

Popular posts from this blog

MOLECULAR THERAPEUTIC TARGETS FOR BREAST CANCER

Image
The recent news in the worldwide breast cancer therapeutics industry is that of a research conducted with respect to conceptualizing a new treatment. Reports uncover that by consolidating cancer therapy with drug therapy stifles tumor blood vessels found in cancer cells, can help fundamentally decrease the spread of breast malignancy tumors while additionally causing cancer cell demise.   Likewise, another study has recognized that 24 beforehand obscure epigenetic changes that modify a woman's danger of breast cancer can be gone down through generations without including changes in the DNA sequence of genes. Specialists at the University of Missouri have done a promising disclosure in breast cancer therapeutics. Generally, the human cell has a transformed p53 protein that assaults potential malignancies.   Be that as it may, in the vicinity of 30% and 40% of human breast malignancies express a defective type of mutant p53 protein which really encourages the cancer c
Read more